These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 31971908

  • 1. Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease.
    Silverman MG, Yeri A, Moorthy MV, Camacho Garcia F, Chatterjee NA, Glinge CSA, Tfelt-Hansen J, Salvador AM, Pico AR, Shah R, Albert CM, Das S.
    JACC Clin Electrophysiol; 2020 Jan; 6(1):70-79. PubMed ID: 31971908
    [Abstract] [Full Text] [Related]

  • 2. miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death.
    Yan F, Chen Y, Ye X, Zhang F, Wang S, Zhang L, Luo X.
    Diagn Pathol; 2021 Jul 31; 16(1):67. PubMed ID: 34332589
    [Abstract] [Full Text] [Related]

  • 3. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
    Roncarati R, Viviani Anselmi C, Losi MA, Papa L, Cavarretta E, Da Costa Martins P, Contaldi C, Saccani Jotti G, Franzone A, Galastri L, Latronico MV, Imbriaco M, Esposito G, De Windt L, Betocchi S, Condorelli G.
    J Am Coll Cardiol; 2014 Mar 11; 63(9):920-7. PubMed ID: 24161319
    [Abstract] [Full Text] [Related]

  • 4. Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death Victims.
    Marí-Alexandre J, Barceló-Molina M, Sanz-Sánchez J, Molina P, Sancho J, Abellán Y, Santaolaria-Ayora ML, Giner J, Martínez-Dolz L, Estelles A, Braza-Boïls A, Zorio E.
    Rev Esp Cardiol (Engl Ed); 2019 Jan 11; 72(1):30-39. PubMed ID: 29439878
    [Abstract] [Full Text] [Related]

  • 5. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM.
    J Transl Med; 2015 Sep 24; 13():314. PubMed ID: 26404540
    [Abstract] [Full Text] [Related]

  • 6. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction.
    Li H, Zhang P, Li F, Yuan G, Wang X, Zhang A, Li F.
    Biomed Res Int; 2019 Sep 24; 2019():5012648. PubMed ID: 31179325
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT, Reinhall PG, Poole JE, Anderson J, Johnson G, Fletcher RD, Moore HJ, Mark DB, Lee KL, Bardy GH.
    Heart Rhythm; 2015 Oct 24; 12(10):2058-66. PubMed ID: 26096609
    [Abstract] [Full Text] [Related]

  • 11. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun 24; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 12. Circulating microRNA profiles based on direct S-Poly(T)Plus assay for detection of coronary heart disease.
    Su M, Niu Y, Dang Q, Qu J, Zhu D, Tang Z, Gou D.
    J Cell Mol Med; 2020 Jun 24; 24(11):5984-5997. PubMed ID: 32343493
    [Abstract] [Full Text] [Related]

  • 13. Correlation of Circulating miR-765, miR-93-5p, and miR-433-3p to Obstructive Coronary Heart Disease Evaluated by Cardiac Computed Tomography.
    Infante T, Forte E, Punzo B, Cademartiri F, Cavaliere C, Soricelli A, Salvatore M, Napoli C.
    Am J Cardiol; 2019 Jul 15; 124(2):176-182. PubMed ID: 31084998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A meta-analysis of dysregulated miRNAs in coronary heart disease.
    Wang SS, Wu LJ, Li JJ, Xiao HB, He Y, Yan YX.
    Life Sci; 2018 Dec 15; 215():170-181. PubMed ID: 30423308
    [Abstract] [Full Text] [Related]

  • 18. Dissecting the roles of microRNAs in coronary heart disease via integrative genomic analyses.
    Huan T, Rong J, Tanriverdi K, Meng Q, Bhattacharya A, McManus DD, Joehanes R, Assimes TL, McPherson R, Samani NJ, Erdmann J, Schunkert H, Courchesne P, Munson PJ, Johnson AD, O'Donnell CJ, Zhang B, Larson MG, Freedman JE, Levy D, Yang X.
    Arterioscler Thromb Vasc Biol; 2015 Apr 15; 35(4):1011-21. PubMed ID: 25657313
    [Abstract] [Full Text] [Related]

  • 19. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
    DU Y, Yang SH, Li S, Cui CJ, Zhang Y, Zhu CG, Guo YL, Wu NQ, Gao Y, Sun J, Dong Q, Liu G, Li JJ.
    Biomed Environ Sci; 2016 Aug 15; 29(8):545-554. PubMed ID: 27660218
    [Abstract] [Full Text] [Related]

  • 20. SCD in the world, Europe, Bosnia and Herzegovina and Mostar.
    Fazlibegovic E, Hadziomerovic M, Dedovic A, Veledar E, Fazlibegovic F.
    Med Arh; 2007 Aug 15; 61(2 Suppl 1):23-6. PubMed ID: 21548414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.